Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tappy, L.
Right arrow Articles by Philippe, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tappy, L.
Right arrow Articles by Philippe, J.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes, Vol 46, Issue 2 204-208, Copyright © 1997 by American Diabetes Association


ARTICLES

Abnormal regulation of hepatic glucose output in maturity-onset diabetes of the young caused by a specific mutation of the glucokinase gene

L Tappy, P Dussoix, P Iynedjian, S Henry, P Schneiter, G Zahnd, E Jequier and J Philippe
Institut de Physiologie, Universite de Lausanne, Switzerland. ltappy@ulys.unil.ch

A subtype of maturity-onset diabetes of the young (MODY) is caused by mutations of the glucokinase gene, an enzyme expressed in pancreatic beta-cells and the liver. To assess the consequences of a functional alteration of glucokinase at the level of the liver, endogenous (hepatic) glucose production and glucose cycling (an indirect assessment of hepatic glucokinase activity) were measured with 2-2H glucose and 6,6-2H glucose in patients who developed MODY because of the V203A mutation of glucokinase, and in control subjects at similar levels of glycemia. Measurements were performed in the postabsorptive state and after ingestion of 13C-labeled glucose. In the postabsorptive state, MODY patients had normal glucose production (10.9 +/- 1.3 vs. 11.3 +/- 0.6 micromol x kg(-1) x min(-1)) but decreased glucose cycling (0.6 +/- 0.3 vs. 1.5 +/- 0.3 micromol x kg(-1) x min(-1); P < 0.05) when compared with control subjects. However, at plasma glucose and insulin levels similar to those observed in MODY patients, control subjects' glucose production was markedly lower (3.2 +/- 1.5 micromol x kg(-1) x min(-1). After glucose ingestion, endogenous glucose production was reduced by only 29% in MODY patients compared with 80% in control subjects at a similar level of hyperglycemia (P < 0.05). This suggests that the V203A mutation of glucokinase results in decreased activity of glucokinase in liver cells. Thus endogenous glucose production is inadequately inhibited by hyperglycemia in MODY patients, possibly as a result of impaired hepatic glucokinase activity. These alterations contribute to the pathogenesis of hyperglycemia.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
V. Rigalleau, M.-C. Beauvieux, J.-L. Gallis, H. Gin, P. Schneiter, and L. Tappy
Effects of hyperglycemia on glucose metabolism before and after oral glucose ingestion in normal men
Am J Physiol Endocrinol Metab, June 1, 2006; 290(6): E1198 - E1204.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
F. Fery, L. Tappy, J. Deviere, and E. O. Balasse
Comparison of intraduodenal and intravenous glucose metabolism under clamp conditions in humans
Am J Physiol Endocrinol Metab, February 1, 2004; 286(2): E176 - E183.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
O. Matzinger, P. Schneiter, and L. Tappy
Effects of fatty acids on exercise plus insulin-induced glucose utilization in trained and sedentary subjects
Am J Physiol Endocrinol Metab, January 1, 2002; 282(1): E125 - E131.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
V. Rigalleau, C. Binnert, K. Minehira, N. Stefanoni, P. Schneiter, E. Henchoz, O. Matzinger, C. Cayeux, E. Jéquier, and L. Tappy
In Normal Men, Free Fatty Acids Reduce Peripheral but Not Splanchnic Glucose Uptake
Diabetes, April 1, 2001; 50(4): 727 - 732.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
P. Battilana, G. Seematter, Ph. Schneiter, E. Jéquier, and L. Tappy
Effects of Free Fatty Acids on Insulin Sensitivity and Hemodynamics during Mental Stress
J. Clin. Endocrinol. Metab., January 1, 2001; 86(1): 124 - 128.
[Abstract] [Full Text]


Home page
Am. J. Clin. Nutr.Home page
J.-M. Schwarz, R. Chiolero, J.-P. Revelly, C. Cayeux, P. Schneiter, E. Jequier, T. Chen, and L. Tappy
Effects of enteral carbohydrates on de novo lipogenesis in critically ill patients
Am. J. Clinical Nutrition, October 1, 2000; 72(4): 940 - 945.
[Abstract] [Full Text] [PDF]


Home page
PhysiologyHome page
L. Tappy, E. Jequier, and P. Schneiter
Autoregulation of Glucose Production
Physiology, August 1, 2000; 15(4): 198 - 202.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Postic, M. Shiota, K. D. Niswender, T. L. Jetton, Y. Chen, J. M. Moates, K. D. Shelton, J. Lindner, A. D. Cherrington, and M. A. Magnuson
Dual Roles for Glucokinase in Glucose Homeostasis as Determined by Liver and Pancreatic beta  Cell-specific Gene Knock-outs Using Cre Recombinase
J. Biol. Chem., January 1, 1999; 274(1): 305 - 315.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
P. Schneiter and L. Tappy
Kinetics of dexamethasone-induced alterations of glucose metabolism in healthy humans
Am J Physiol Endocrinol Metab, November 1, 1998; 275(5): E806 - E813.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 1997 by the American Diabetes Association.